Animal Therapeutics and Diagnostics

Report Code: HLC034B

Publish Date: Jul 2008

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for animal therapeutics and diagnostics is expected to be worth $24.1 billion in 2008, up from $22.3 billion in 2007. This should increase to $33.0 billion in 2013, a compound annual growth rate (CAGR) of 6.5%.
  • The animal therapeutics segment dominates the market, generating $21.8 billion in 2007 and an estimated $23.6 billion in 2008 and $32.4 billion in 2012, a CAGR of 6.6%.
  • Diagnostics for animals were worth $474 million in 2007. This should increase to $498 million in 2008 and $624 million in 2013, for a CAGR of 4.6%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
This BCC Research report, Animal Therapeutics and Diagnostics, provides an overview of products included in this market, and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutic and diagnostic market.
 
REASONS FOR DOING THE STUDY 
 
 
The animal health industry is responsible for maintaining the health and productivity of the over 3.3 billion livestock and 16 billion poultry worldwide, and ensuring the wholesomeness and abundance of the food they produce. In addition, the industry must also cater to the health and well being of companion animals. Despite this, the human healthcare market is 35 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates, and being the first to market. Despite all these risks, the industry continues to grow.
 
In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by large numbers of products with small revenues. Although there are hundreds of products involved in this market, only about 20 products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the arthritis and pain segments of the market.
 
A challenging aspect of the market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment as animals produce minimal amounts of manure.
 
INTENDED AUDIENCE
 
The information within this report is directed at the business and industry professional and is specifically designed to aid in the explanation, direction, and future of animal health markets. The report focuses on providing the reader with an understanding of trends in the industry, market segments, market forecasts, leading players, market drivers and inhibitors.
 
SCOPE OF REPORT 
 
 
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutic and diagnostic market. The geographical scope of this study is worldwide, with special interest in U.S. trends and statistics. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics includes products that are used at the point of care and are considered rapid tests or kits. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.
 
INFORMATION SOURCES
 
The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 50 key executives, product managers, and clinical specialists involved in the animal health industry. Secondary methods included published literature in the area of animal science and veterinary services, investment reports, company literature, and various animal health journals.
 
All market data pertains to the global market at the manufacturers’ level. Data is expressed in current U.S. dollars. The base year of the report is 2007, with historical data provided for 2006, and forecast data provided for 2008 and 2013. Historical, base year and forecast data is provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2007 base year.
 
Although this study provides information on a variety of products used to treat animals, it does not include a comprehensive list of all products available. 
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Animal Therapeutics and Diagnostics206Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: INDUSTRY OVERVIEW69Free
Chapter- 4: ANIMAL VACCINES27Free
Chapter- 5: ANIMAL PHARMACEUTICAL PRODUCTS39Free
Chapter- 6: ANIMAL FEED ADDITIVES22Free
Chapter- 7: ANIMAL DIAGNOSTICS14Free
Chapter- 8: MARKET SUMMARY6Free
Chapter- 9: C. CRAMER & CO. GMBH14Free
Chapter- 10: APPENDIX I: LEADING MANUFACTURES AND AFFILIATED COMPANIES8Free
Chapter- 11: APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS1Free
Published - Jun-2004| Analyst - Melissa Elder| Code - HLC034A

Report Highlights

  • The total worldwide market for animal therapeutics and diagnostics was estimated at more than $15.6 billion in 2003 and by 2008 is likely to reach $19.6 billion, at an average annual growth rate (AAGR) of 4.7%.
  • Animal therapeutics, e.g., vaccines, pharmaceuticals, and feed additives, are valued at $15.1 billion, and rising at an AAGR of 4.7%.
  • Pharmaceuticals account for the largest percentage of revenues at nearly 54%.
  • Feed additives are the second largest market segment due to demand from the food animal producer segment.
  • Diagnostic products account for a smaller portion of the market

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Flame Retardant Chemicals: Technologies and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - CHM014Q

The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.

Biorefinery Products: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - EGY117D

The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

Electric Vehicle Charging: Infrastructure and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - FCB045B

The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Animal Therapeutics and Diagnostics
Customize Report